PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ACLX vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

ACLX vs. OLMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
72.27%
-9.85%
ACLX
OLMA

Returns By Period

In the year-to-date period, ACLX achieves a 57.15% return, which is significantly higher than OLMA's -43.91% return.


ACLX

YTD

57.15%

1M

-3.58%

6M

72.27%

1Y

63.39%

5Y (annualized)

N/A

10Y (annualized)

N/A

OLMA

YTD

-43.91%

1M

-36.84%

6M

-9.85%

1Y

-42.76%

5Y (annualized)

N/A

10Y (annualized)

N/A

Fundamentals


ACLXOLMA
Market Cap$4.72B$474.43M
EPS-$0.71-$2.28
Total Revenue (TTM)$155.82M$1.88M
Gross Profit (TTM)$153.03M$1.61M
EBITDA (TTM)-$42.54M-$135.54M

Key characteristics


ACLXOLMA
Sharpe Ratio1.37-0.60
Sortino Ratio1.98-0.63
Omega Ratio1.230.93
Calmar Ratio2.12-0.52
Martin Ratio4.24-1.62
Ulcer Index16.14%27.58%
Daily Std Dev50.11%74.60%
Max Drawdown-62.33%-96.26%
Current Drawdown-18.13%-85.56%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.2

The correlation between ACLX and OLMA is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

ACLX vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ACLX, currently valued at 1.37, compared to the broader market-4.00-2.000.002.004.001.37-0.60
The chart of Sortino ratio for ACLX, currently valued at 1.98, compared to the broader market-4.00-2.000.002.004.001.98-0.63
The chart of Omega ratio for ACLX, currently valued at 1.23, compared to the broader market0.501.001.502.001.230.93
The chart of Calmar ratio for ACLX, currently valued at 2.12, compared to the broader market0.002.004.006.002.12-0.82
The chart of Martin ratio for ACLX, currently valued at 4.24, compared to the broader market0.0010.0020.0030.004.24-1.62
ACLX
OLMA

The current ACLX Sharpe Ratio is 1.37, which is higher than the OLMA Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of ACLX and OLMA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
1.37
-0.60
ACLX
OLMA

Dividends

ACLX vs. OLMA - Dividend Comparison

Neither ACLX nor OLMA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ACLX vs. OLMA - Drawdown Comparison

The maximum ACLX drawdown since its inception was -62.33%, smaller than the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for ACLX and OLMA. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-18.13%
-54.08%
ACLX
OLMA

Volatility

ACLX vs. OLMA - Volatility Comparison

The current volatility for Arcellx Inc (ACLX) is 16.75%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 20.61%. This indicates that ACLX experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
16.75%
20.61%
ACLX
OLMA

Financials

ACLX vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Arcellx Inc and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items